Post-Transplant Cyclophosphamide as a Potent Strategy for Bronchiolitis Obliterans Syndrome Prevention: A Comprehensive Clinical Synthesis

Post-Transplant Cyclophosphamide as a Potent Strategy for Bronchiolitis Obliterans Syndrome Prevention: A Comprehensive Clinical Synthesis

This review evaluates the role of post-transplant cyclophosphamide (PTCy) in reducing the risk of bronchiolitis obliterans syndrome (BOS), highlighting recent multicenter data that demonstrates a 75% risk reduction mediated by the prevention of chronic graft-versus-host disease.
Predicting Ocular Relapse in Sarcoid Uveitis: Macular Edema and Baseline Inflammation as Critical Prognostic Markers

Predicting Ocular Relapse in Sarcoid Uveitis: Macular Edema and Baseline Inflammation as Critical Prognostic Markers

A multicentric study of 336 patients reveals that two-thirds of sarcoid uveitis cases experience relapse, primarily driven by baseline macular edema and persistent inflammation. Despite high recurrence rates, long-term visual prognosis remains favorable for most, with low rates of severe vision loss over nearly eight years.
Reduced Intestinal Epithelial GPX4 Expression Predicts Postoperative Crohn’s Disease Recurrence and Offers a Novel Therapeutic Target

Reduced Intestinal Epithelial GPX4 Expression Predicts Postoperative Crohn’s Disease Recurrence and Offers a Novel Therapeutic Target

A breakthrough study identifies epithelial Glutathione peroxidase 4 (GPX4) deficiency as a potent predictor of Crohn's disease recurrence after surgery. The research links this biomarker to endoplasmic reticulum stress and highlights selenium supplementation as a potential druggable strategy to improve patient outcomes.
High Basal Ganglia Perivascular Space Burden Predicts Both Ischemic Stroke and Major Bleeding in Antithrombotic Users

High Basal Ganglia Perivascular Space Burden Predicts Both Ischemic Stroke and Major Bleeding in Antithrombotic Users

A large prospective study reveals that a high burden of basal ganglia enlarged perivascular spaces (BGPVSs) significantly increases the risk of both ischemic stroke and major bleeding in patients on antithrombotic therapy, positioning BGPVS as a critical biomarker for personalized vascular risk assessment.